Planning

RSV 2024

UK HEALTH SECURITY AGENCY

This public procurement record has 1 release in its history.

Planning

27 Nov 2023 at 11:06

Planned Procurement Notice
Summary of the contracting process

The UK Health Security Agency has initiated a tender process titled "RSV 2024" for the provision of immunisation products related to Respiratory Syncytial Virus (RSV) lower respiratory tract disease. This procurement falls under the goods category, with an estimated contract period starting on 1st July 2024 and ending on 30th June 2028. The contracting authority anticipates potential deliveries of up to 4 million doses across different lots. The procurement method for this opportunity is an open procedure above the threshold, with future notice communication set for 15th January 2024.

This tender from the UK Health Security Agency provides growth opportunities for businesses involved in vaccines, immune sera, and immunoglobulins. Companies interested in supplying immunisation products and operating in the United Kingdom would be well-suited to compete for this contract. The four different lots specified in the tender offer scope for a wide range of businesses to participate and potentially expand their market presence within the healthcare industry.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

RSV 2024

Notice Description

The provision of immunisation products indicated for the prevention or protection from Respiratory Syncytial Virus (RSV) lower respiratory tract disease The contracting authority estimates their requirement for deliveries between 1 July 2024 to 30 June 2026 ('Initial Term') of the contract to be up to 1.6 million doses for Lot 1, up to 1.69 million doses for Lot 2, up to 1.45 million doses for Lot 3 or up to 4 million doses for Lot 4, with the option to extend for up to an additional 24 months.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-598dc806-e973-4aeb-9562-692b5e6d1902
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/bdda5b73-5ff0-49f9-83d4-7ac7cf0acf01
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planned Procurement Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651500 - Immune sera and immunoglobulins

33651600 - Vaccines

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
27 Nov 20232 years ago
Submission Deadline
Not specified
Future Notice Date
15 Jan 2024Expired
Award Date
Not specified
Contract Period
30 Jun 2024 - 30 Jun 2028 4-5 years
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
UK HEALTH SECURITY AGENCY
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Post Town
East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified
Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-598dc806-e973-4aeb-9562-692b5e6d1902-2023-11-27T11:06:03Z",
    "date": "2023-11-27T11:06:03Z",
    "ocid": "ocds-b5fd17-598dc806-e973-4aeb-9562-692b5e6d1902",
    "language": "en",
    "initiationType": "tender",
    "planning": {
        "documents": [
            {
                "id": "1",
                "documentType": "plannedProcurementNotice",
                "description": "Future opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/bdda5b73-5ff0-49f9-83d4-7ac7cf0acf01",
                "datePublished": "2023-11-27T11:06:03Z",
                "format": "text/html",
                "language": "en"
            },
            {
                "id": "2",
                "description": "Published PIN",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/a0053de4-9358-47c3-8142-527a31325493",
                "format": "application/pdf"
            }
        ]
    },
    "tender": {
        "id": "CF-1989400D0O000000rwimUAA",
        "title": "RSV 2024",
        "description": "The provision of immunisation products indicated for the prevention or protection from Respiratory Syncytial Virus (RSV) lower respiratory tract disease The contracting authority estimates their requirement for deliveries between 1 July 2024 to 30 June 2026 ('Initial Term') of the contract to be up to 1.6 million doses for Lot 1, up to 1.69 million doses for Lot 2, up to 1.45 million doses for Lot 3 or up to 4 million doses for Lot 4, with the option to extend for up to an additional 24 months.",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "33651600",
            "description": "Vaccines"
        },
        "additionalClassifications": [
            {
                "scheme": "CPV",
                "id": "33651500",
                "description": "Immune sera and immunoglobulins"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure (above threshold)",
        "communication": {
            "futureNoticeDate": "2024-01-15T23:59:59Z"
        },
        "contractPeriod": {
            "startDate": "2024-07-01T00:00:00+01:00",
            "endDate": "2028-06-30T23:59:59+01:00"
        },
        "suitability": {
            "sme": false,
            "vcse": false
        },
        "mainProcurementCategory": "goods"
    },
    "parties": [
        {
            "id": "GB-CFS-254798",
            "name": "UK Health Security Agency",
            "identifier": {
                "legalName": "UK Health Security Agency"
            },
            "address": {
                "streetAddress": "10 South Colonnade",
                "locality": "London",
                "postalCode": "E14 4PU",
                "countryName": "GB"
            },
            "contactPoint": {
                "name": "Chantal Jockel",
                "email": "chantal.jockel@ukhsa.gov.uk"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-254798",
        "name": "UK Health Security Agency"
    }
}